Related content

Identification of novel protective antigens from Anaplasma marginale

By Riding G.   Hope M.   Waltisbuhl D.   Willadsen P.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1874-1883

Elsevier

Access to resources Recommend Favorite

Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis

By Bhaskar S.   Khanna S.P.   Mukherjee R.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2856-2866

Elsevier

Access to resources Recommend Favorite

Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine

By Serezani C.H.C.   Franco A.R.   Wajc M.   Umada Yokoyama-Yasunaka J.K.   Wunderlich G.   Borges M.M.   Uliana S.R.B.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3755-3763

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii

By Supply P.   Sutton P.   Coughlan S.N.   Bilo K.   Saman E.   Trees A.J.   Cesbron Delauw M.-F.   Locht C.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 705-714

Elsevier

Access to resources Recommend Favorite